MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Toxic Shock Syndrome

Active Clinical Trials

Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 150
  • Start Date: June 8, 2020
Verbesserung Einer gestörten zerebrovaskulären Autoregulation Bei Patienten im Septischen Schock Durch Extrakorporale Reduktion Von Entzündungsmediatoren
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 80
  • Start Date: June 6, 2020
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 130
  • Start Date: April 3, 2020
Terlipressin Versus Placebo for Septic Shock Refractory to High Doses Catecholamine Vasopressors: A Randomized-controlled Trial
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 32
  • Start Date: January 1, 2020
Effect of the CytoSorb Adsorber on Hemodynamic, Immunological and Pharmacokinetic Parameters in Refractory Septic Shock
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 100
  • Start Date: December 1, 2019
Early Identification of Sepsis in Children
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 260
  • Start Date: November 25, 2019
Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 44
  • Start Date: November 14, 2019
Effectiveness of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg on Capillary Perfusion Density, Acute Kidney Injury Stage, Cardiac Index, and the Intensive Care Unit Length of Stay in Septic Shock Patients After Resuscitation
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 1662
  • Start Date: October 21, 2019
Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 305
  • Start Date: October 21, 2019
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 90
  • Start Date: October 4, 2019
Utility of Sodium Lactate Infusion During Septic Shock: Pilot Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 50
  • Start Date: September 1, 2019
Difference in Mortality and Evolution in Septic Patients Treated With Vitamin C, Tiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone Treated at the ICU of General Hospital Zone 11 IMSS Piedras Negras Coahuila.
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 30
  • Start Date: July 1, 2019
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Patients With Severe Septic Shock
Showing 1–12 of 36 Clinical Trials
Next